These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31970413)

  • 1. Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults.
    Hanlon EC; Leproult R; Stuhr KL; Doncheck EM; Hillard CJ; Van Cauter E
    J Clin Endocrinol Metab; 2020 Mar; 105(3):792-802. PubMed ID: 31970413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol.
    Hanlon EC; Tasali E; Leproult R; Stuhr KL; Doncheck E; de Wit H; Hillard CJ; Van Cauter E
    J Clin Endocrinol Metab; 2015 Jan; 100(1):220-6. PubMed ID: 25368979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol.
    Hanlon EC; Tasali E; Leproult R; Stuhr KL; Doncheck E; de Wit H; Hillard CJ; Van Cauter E
    Sleep; 2016 Mar; 39(3):653-64. PubMed ID: 26612385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
    Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
    PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women.
    Fanelli F; Mezzullo M; Belluomo I; Di Lallo VD; Baccini M; Ibarra Gasparini D; Casadio E; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
    Mol Metab; 2017 May; 6(5):406-415. PubMed ID: 28462075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men.
    Mäntele S; Otway DT; Middleton B; Bretschneider S; Wright J; Robertson MD; Skene DJ; Johnston JD
    PLoS One; 2012; 7(5):e37123. PubMed ID: 22623983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors.
    Di Marzo V; Côté M; Matias I; Lemieux I; Arsenault BJ; Cartier A; Piscitelli F; Petrosino S; Alméras N; Després JP
    Diabetologia; 2009 Feb; 52(2):213-7. PubMed ID: 18972095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
    Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.
    Navarini L; Bisogno T; Mozetic P; Piscitelli F; Margiotta DPE; Basta F; Afeltra A; Maccarrone M
    Int J Biochem Cell Biol; 2018 Jun; 99():161-168. PubMed ID: 29655919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Milk Endocannabinoid Levels as a Function of Obesity and Diurnal Rhythm.
    Datta P; Melkus MW; Rewers-Felkins K; Patel D; Bateman T; Baker T; Hale TW
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
    Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
    Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
    Di Marzo V; Verrijken A; Hakkarainen A; Petrosino S; Mertens I; Lundbom N; Piscitelli F; Westerbacka J; Soro-Paavonen A; Matias I; Van Gaal L; Taskinen MR
    Eur J Endocrinol; 2009 Nov; 161(5):715-22. PubMed ID: 19745037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoylethanolamide and human neural responses to food stimuli in obesity.
    Grosshans M; Schwarz E; Bumb JM; Schaefer C; Rohleder C; Vollmert C; Vollstädt-Klein S; Tost H; Meyer-Lindenberg A; Kiefer F; Leweke FM
    JAMA Psychiatry; 2014 Nov; 71(11):1254-61. PubMed ID: 25229205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.